The Case for and Against Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers – Major. The stock has been active on the tape, currently trading at $52.74, up from yesterday’s close by 1.02%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Bristol-Myers Squibb Company (BMY) currently trades with a market capitalization of $86.12 Billion. That value represents a market adjusting for revenues that have been growing by 5.36 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $4.59 Billion over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of $0.86 on a per share basis this quarter. Perhaps, that suggests something about why 0.38% of the outstanding share supply is held by institutional investors.



Technical Analysis

It’s important to check the technicals to get a sense of how BMY has been acting. Looking at the stock’s movement on the chart, Bristol-Myers Squibb Company recorded a 52-week high of $70.05. It is now trading 17.31% off that level. The stock is trading $57.98 its 50-day moving average by 5.24%. The stock carved out a 52-week low down at $49.96.

In recent action, Bristol-Myers Squibb Company (BMY) has made a move of +2.19% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 15.08, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 0.78% with $1.63 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of BMY.

SHARE
Previous articleDrilling Down Into Avon Products, Inc. (AVP)
Next articleJust the Facts on DowDuPont Inc. (DWDP)